Advanced Brain Monitoring Inc has initiated the worldwide launch of Apnea Guard, a temporary oral appliance cleared by the FDA to be fitted for a patient by a trained health care professional and worn for up to 30 nights.

“Apnea Guard addresses the need identified during a $1 million National Institute of Dental and Craniofacial Research study designed to improve clinical outcomes with oral appliance therapy,” said Dan Levendowski, principal investigator. “The scientific evidence strongly supports the use of mandibular advancement for the treatment of sleep apnea. The missing link to wide-spread adoption of custom appliances is access to easy, accurate, and inexpensive identification of patients who will benefit from oral appliance therapy based on a multiple night trial.”

“We developed a patent-pending system that allows clinicians with limited expertise in the delivery of oral appliance therapy to have immediate success. Fitting Apnea Guard is similar to making impressions,” said Dr Todd Morgan, co-inventor. “What makes Apnea Guard unique is the capability to transfer the optimized setting directly to a custom oral appliance.”

Apnea Guard will be introduced at the American Academy of Sleep Medicine and American Academy of Dental Sleep Medicine conferences June 6-13, 2012 in Boston.